Raised serum amylase in patients with COVID-19 may not be associated with pancreatitis

J R Stephens; J L C Wong; R Broomhead; R Stümpfle; U Waheed; P Patel; S J Brett; S Soni

doi:10.1093/bjs/znaa168

Raised serum amylase in patients with COVID-19 may not be associated with pancreatitis

Br J Surg. 2021 Apr 30;108(4):e152-e153. doi: 10.1093/bjs/znaa168.

Authors

J R Stephens¹, J L C Wong², R Broomhead³, R Stümpfle³, U Waheed³, P Patel³, S J Brett^{3

4}, S Soni^{3

4}

Affiliations

¹ Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
² MRC Centre for Molecular Bacteriology and Infection, Department of Life Sciences, Imperial College London, London, UK.
³ Hammersmith Hospital , Imperial College Healthcare NHS Trust, London, UK.
⁴ Department of Surgery and Cancer, Division of Anaesthetics, Pain Medicine and Intensive Care, Imperial College London, London, UK.

Abstract

A high incidence of pancreatitis in COVID-19 has been reported. Although a high proportion of critically unwell patients with COVID-19 have raised serum amylase levels, this does not necessarily reflect acute pancreatitis or a clinically important pancreatic injury.

Publication types

Editorial

MeSH terms

Acute Disease
Amylases / blood*
Biomarkers / blood
COVID-19 / epidemiology*
Comorbidity
Female
Humans
Incidence
Male
Middle Aged
Pancreatitis / blood*
Pancreatitis / epidemiology
Pandemics*
SARS-CoV-2
United Kingdom / epidemiology

Substances

Biomarkers
Amylases